针灸治疗纤维肌痛:基于多维证据的综述
纤维肌痛(FM)以广泛慢性疼痛、疲劳、睡眠障碍和认知功能障碍为特征,目前无特异性治疗。本文综述了针灸治疗FM的操作方法,首次系统整合患者与动物模型证据,探讨针灸可能通过调控ASIC3、Nav1.7、Nav1.8、TRPV1等分子及外周炎症和自主神经系统改善症状,并回顾了临床研究,认为针灸是有前景的疗法但需进一步研究。
要点
- 针灸可能通过调控疼痛传入与下行抑制通路相关分子改善FM症状。
- 综述整合了FM患者与动物模型的机制证据及临床研究。
- 针灸治疗FM的临床发现尚不一致,需进一步研究验证。
核心结论
- 针灸可能是有前景的FM症状治疗手段,但需进一步研究。
研究设计与样本
- 综述整合了FM患者与动物模型研究,并回顾针灸相关临床研究。
主要发现
- 针灸可能通过调控ASIC3、Nav1.7、Nav1.8、TRPV1等分子及外周炎症和自主神经系统改善FM症状。
- 已有研究显示针灸可使FM患者获益,但临床发现不一致。
临床怎么用
- 综述总结了针灸治疗FM的操作方法,可供临床参考。
局限性
- 针灸治疗FM的临床研究结果不一致,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fibromyalgia (FM) is a complicated syndrome characterized by widespread chronic pain, fatigue, sleep disturbances, cognitive dysfunction, and other complications. There is currently no specific treatment available. No comprehensive surveys have been published to summarize the mechanism of acupuncture in FM management. Although several studies have shown that acupuncture can benefit FM patients, their clinical findings are inconsistent. Here, we summarize the operation method of acupuncture for FM. For the first time, we conducted a comprehensive review of the mechanisms of acupuncture for FM, and integrated evidence-based scientific findings with the most comprehensive and updated literature. According to studies conducted using FM patients and animal models, acupuncture may improve symptoms in FM patients by regulating the afferent pain pathway and descending inhibitory pain pathways of various molecules, such as ASIC3, Nav1.7, Nav1.8, and TRPV1, as well as peripheral inflammation and the autonomic nervous system. Furthermore, we discussed the epidemiology, pathophysiology, diagnosis, and management of FM, and reviewed acupuncture-related clinical studies. This review fills a previously unknown gap in knowledge of the mechanism of acupuncture for FM. Although there is growing evidence that acupuncture may be a promising therapy for treating symptoms in FM patients, further investigation is needed.
引用
- Han D, Lu Y, Huang R, et al. Acupuncture for Fibromyalgia: A Review Based on Multidimensional Evidence. Am J Chin Med. 2023. PMID: 36599648. doi:10.1142/S0192415X23500143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。